There is growing evidence that exercise-induced variation in lung volumes is an important source of ventilatory limitation and is linked to exercise intolerance in COPD. The aim of this study was to compare the correlations of walk distance and lung volumes measured before and after a 6-min walk test (6MWT) in subjects with COPD.
METHODS:
Forty-five subjects with stable COPD (mean pre-bronchodilator FEV1: 47 ± 18% predicted) underwent a 6MWT. Body plethysmography was performed immediately pre- and post-6MWT.
RESULTS:
Correlations were generally stronger between 6-min walk distance and post-6MWT lung volumes than between 6-min walk distance and pre-6MWT lung volumes, except for FEV1. These differences in Pearson correlation coefficients were significant for residual volume expressed as percent of total lung capacity (−0.67 vs −0.58, P = .043), percent of predicted residual volume expressed as percent of total lung capacity (−0.68 vs −0.59, P = .026), inspiratory vital capacity (0.65 vs 0.54, P = .019), percent of predicted inspiratory vital capacity (0.49 vs 0.38, P = .037), and percent of predicted functional residual capacity (−0.62 vs −0.47, P = .023).
CONCLUSIONS:
In subjects with stable COPD, lung volumes measured immediately after 6MWT are more closely related to exercise limitation than baseline lung volumes measured before 6MWT, except for FEV1. Therefore, pulmonary function testing immediately after exercise should be included in future studies on COPD for the assessment of exercise-induced ventilatory constraints to physical performance that cannot be adequately assessed from baseline pulmonary function testing at rest.
MacNeeW. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005; 2(4):258–266.
4.
Puente-MaestuL, StringerWW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis, 2006; 1(4):381–400.
5.
O'DonnellDE, WebbKA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol, 2008; 105(2):753–755; discussion 755-757.
6.
LarssonK. Aspects on pathophysiological mechanisms in COPD. J Intern Med, 2007; 262(3):311–340.
7.
BauerleO, ChruschCA, YounesM. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med, 1998; 157(1):57–68.
8.
MarinJM, CarrizoSJ, GasconM, SanchezA, GallegoB, CelliBR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001; 163(6):1395–1399.
9.
WijkstraPJ, TenVergertEM, van der MarkTW, PostmaDS, Van AltenaR, KraanJ, KoëterGH. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax, 1994; 49(5):468–472.
10.
SpruitMA, WatkinsML, EdwardsLD, VestboJ, CalverleyPM, Pinto-PlataV, et al. Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med, 2010; 104(6):849–857.
11.
CallensE, GrabaS, Gillet-JuvinK, EssalhiM, Bidaud-ChevalierB, PeifferC, et al. Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest, 2009; 136(6):1466–1472.
12.
LavenezianaP, ParkerCM, O'DonnellDE. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease. Appl Physiol Nutr Metab, 2007; 32(6):1225–1238.
13.
RedelmeierDA, BayoumiAM, GoldsteinRS, GuyattGH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med, 1997; 155(4):1278–1282.
14.
PapaioannouAI, LoukidesS, GourgoulianisKI, KostikasK. Global assessment of the COPD patient: time to look beyond FEV1?. Respir Med, 2009; 103(5):650–660.
15.
MakVH, BuglerJR, RobertsCM, SpiroSG. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax, 1993; 48(1):33–38.
16.
CarterR, HolidayDB, NwasurubaC, StocksJ, GrothuesC, TiepB. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest, 2003; 123(5):1408–1415.
17.
FujimotoH, AsaiK, WatanabeT, KanazawaH, HirataK. Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Osaka City Med J, 2011; 57(1):21–29.
18.
O'DonnellDE, RevillSM, WebbKA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2001; 164(5):770–777.
19.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166(1):111–117.
20.
BorgGA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 1982; 14(5):377–381.
21.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesA, et al. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319–338.
22.
WangerJ, ClausenJL, CoatesA, PedersenOF, BrusascoV, BurgosF, et al. Standardisation of the measurement of lung volumes. Eur Respir J, 2005; 26(3):511–522.
23.
PellegrinoR, ViegiG, BrusascoV, CrapoRO, BurgosF, CasaburiR, et al. Interpretative strategies for lung function tests. Eur Respir J, 2005; 26(5):948–968.
24.
QuanjerPH, TammelingGJ, CotesJE, PedersenOF, PeslinR, YernaultJC. Lung volumes and forced ventilatory flows; report from working party standardization of lung function tests, European Community for Steel and Coal; official statement of the European Respiratory Society. Eur Respir J Suppl, 1993; 16:5–40.
25.
FaulF, ErdfelderE, BuchnerA, LangAG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods, 2009; 41(4):1149–1160.
26.
WibmerT, RüdigerS, HeitnerC, Kropf-SanchenC, BlantaI, StoiberKM, et al. Effects of nasal positive expiratory pressure on dynamic hyperinflation and 6-minute walk test in patients with COPD. 2014; 59(5):699–708.
27.
SteigerJH. Tests for comparing elements of a correlation matrix. Psychol Bull, 1980; 87(2):245–251.
28.
ShapiroSS, WilkMB. An analysis of variance test for normality (complete samples). Biometrika, 1965; 52(3/4):591.
29.
DiazO, VillafrancaC, GhezzoH, BorzoneG, LeivaA, Milic-EmilJ, LisboaC. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J, 2000; 16(2):269–275.
30.
EfremidisG, TsiamitaM, ManolisA, SpiropoulosK. Accuracy of pulmonary function tests in predicted exercise capacity in COPD patients. Respir Med, 2005; 99(5):609–614.
31.
KnoxAJ, MorrisonJF, MuersMF. Reproducibility of walking test results in chronic obstructive airways disease. Thorax, 1988; 43(5):388–392.
32.
CamargoLA, PereiraCA. Dyspnea in COPD: beyond the modified Medical Research Council scale. J Bras Pneumol, 2010; 36(5):571–578.
33.
FreitasCG, PereiraCA, ViegasCA. Inspiratory capacity, exercise limitation, markers of severity, and prognostic factors in chronic obstructive pulmonary disease. J Bras Pneumol, 2007; 33(4):389–396.
34.
van GestelAJR, KohlerM, SteierJ, SommerwerckU, TeschlerS, RussiEW, TeschlerH. Cardiac autonomic function and cardiovascular response to exercise in patients with chronic obstructive pulmonary disease. COPD, 2012; 9(2):160–165.
35.
SpenceDP, HayJG, CarterJ, PearsonMG, CalverleyPM. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide. Thorax, 1993; 48(11):1145–1150.
36.
ChuangML, LinIF, WassermanK. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients. Respir Med, 2001; 95(7):618–626.
37.
ERS Task Force, PalangeP, WardSA, CarlsenKH, CasaburiR, GallagherCG, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J, 2007; 29(1):185–209.
38.
BrownRH, PearseDB, PyrgosG, LiuMC, TogiasA, PermuttS. The structural basis of airways hyperresponsiveness in asthma. J Appl Physiol, 2006; 101(1):30–39.
39.
IrvinCG. Lessons from structure-function studies in asthma: myths and truths about what we teach. J Appl Physiol, 2006; 101(1):7–9.
40.
StubbingDG, PengellyLD, MorseJL, JonesNL. Pulmonary mechanics during exercise in normal males. J Appl Physiol, 1980; 49(3):506–510.
41.
MonteiroMB, BertonDC, MoreiraMA, Menna-BarretoSS, TeixeiraPJ. Effects of expiratory positive airway pressure on dynamic hyperinflation during exercise in patients with COPD. Respir Care, 2012; 57(9):1405–1412.
42.
StreinerDL. Regression in the service of the superego: the do's and don'ts of stepwise multiple regression. Can J Psychiatry, 1994; 39(4):191–196.
43.
WhittinghamMJ, StephensPA, BradburyRB, FreckletonRP. Why do we still use stepwise modelling in ecology and behaviour?. J Anim Ecol, 2006; 75(5):1182–1189.
44.
CazzolaM, MacNeeW, MartinezFJ, RabeKF, FranciosiLG, BarnesPJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J, 2008; 31(2):416–469.
45.
FioreC, LeeA, McDonaldC, HillC, HollandA. Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?. Chron Respir Dis, 2011; 8(3):181–184.
46.
ChuangML, LinIF, ChenSP. Kinetics of changes in oxyhemoglobin saturation during walking and cycling tests in COPD. Respir Care, 2014; 59(3):353–362.
47.
NicoliniA, MerliakF, BarlasciniC. Use of positive expiratory pressure during six minute walk test: results in patients with moderate to severe chronic obstructive pulmonary disease. Multidiscip Respir Med, 2013; 8(1):19.
48.
ChenS, WuYT, LinJJ, LeeCN, HuangCY, ChiangLL. The correlations of the six-minute walk test and respiratory functions in chronic obstructive pulmonary disease patients with chronic hypercapnia. J Exp Clin Med, 2012; 4(1):47–51.
49.
KitaguchiY, FujimotoK, KomatsuY, HanaokaM, HondaT, KuboK. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators. Respir Med, 2013; 107(3):394–400.
50.
O'DonnellDE, LamM, WebbKA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999; 160(2):542–549.
51.
CalverleyPM. Dynamic hyperinflation: is it worth measuring?. Proc Am Thorac Soc, 2006; 3(3):239–244.
52.
ChandraD, KulkarniHS, SciurbaF. Learning from the learning effect in the six-minute-walk test. Am J Respir Crit Care, 2012; 185(6):684–684.
